The Agency for Healthcare Research and Quality has terminated more than 100 grants, resulting in the loss of $131.3 million in committed funding that was scheduled to continue, according to AcademyHealth, an organization representing health-services and health-policy researchers. The cuts affect grants across 28 states, with AHRQ citing the need to discontinue certain non-competing continuation grants and jointly funded awards.
Researchers began receiving cancellation notices earlier this month. The Health and Human Services Department, which oversees AHRQ, stated that the agency determined these particular grants would not receive continuation awards. Termination letters referenced the “best interest of the federal government” as justification but did not provide detailed explanations for why individual canceled grants were deemed contrary to federal interests. HHS did not confirm or deny AcademyHealth’s financial figures when contacted.
AcademyHealth has established a public database documenting the canceled grants to provide transparency on the scope of the cuts. Aaron Carroll, the organization’s president and chief executive officer, noted that researchers initially had no clear picture of the total impact when cancellations began. He emphasized that the financial tally alone does not fully represent the consequences, as the affected funding supported the development of future researchers and investigations into methods for improving healthcare safety and affordability.
Many of the canceled grants addressed research priorities that AHRQ had previously identified as important to preserve, according to Carroll’s statement. The agency funds efforts aimed at strengthening the nation’s healthcare system through research initiatives and training programs for emerging scientists and clinicians. The cancellations raise questions about the coordination between stated agency priorities and implementation of funding decisions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI